New HBF boss warns private hospitals to reduce profits
Por um escritor misterioso
Descrição
10-K
SEC Filing Beam Therapeutics
HBF chief fears tipping point for health insurers
Crispr Therapeutics AG - 10K - Annual Report - February 21, 2023
Vaccination Hesitation: 10 Ways Physicians Can Help
Italian design brands warn of economic catastrophe in manifesto
Health merger: HCF, HBF take on majors
CineMart Projects 2012 - International Film Festival Rotterdam
SEC Filing - bluebird bio, Inc.
SEC Filing Sangamo Therapeutics, Inc.
SEC Filing CRISPR Therapeutics
SEC Filing Sangamo Therapeutics, Inc.
SEC Filing CRISPR Therapeutics
6: Home in: A Just Energy Transition
de
por adulto (o preço varia de acordo com o tamanho do grupo)
